论文部分内容阅读
本文总结我院73例用三碘甲状腺原氨酸(简称T_3)作抑制试验观察甲亢患者用抗甲状腺药物(简称ATD)治疗后的疗效如下。对象和方法对象及分组:为了观察本试验对甲亢患者长期用ATD治疗的疗效,将试验分为三组。第一组:对照组36例,系本院医务人员及学员,身体健康,近月内未服任何含碘食物及药物。第二组:T_3、T_4正常组53例。本组的选择条件为①甲亢诊断肯定;②用ATD
This article summarizes 73 cases of our hospital with triiodothyronine (hereinafter referred to as T_3) for inhibition test observed hyperthyroidism patients with anti-thyroid drugs (referred to as ATD) after treatment as follows. Subjects and Methods Subjects and Groups: In order to observe the long-term treatment of hyperthyroidism with ATD in this trial, the trials were divided into three groups. The first group: control group of 36 cases, Department of hospital medical staff and students, in good health, not taking any iodine-containing food and drugs in recent months. The second group: T_3, T_4 normal group of 53 cases. The selection criteria for this group ① positive diagnosis of hyperthyroidism; ② ATD